Vertex Joins Protein Degradation Space with Kymera Therapeutics Collaboration
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 5 (Table of Contents)
Published: 23 May-2019
DOI: 10.3833/pdr.v2019.i5.2428 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Signalling that it also sees promise in the targeted protein degradation space, Vertex has entered a four-year collaboration with Kymera Therapeutics to develop up to six small molecule protein degraders...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018